Rankings
▼
Calendar
BHVN FY 2025 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$745M
Net Income
-$739M
EPS (Diluted)
$-6.86
Cash Flow
Operating Cash Flow
-$609M
Free Cash Flow
-$610M
Stock-Based Comp.
$112M
Balance Sheet
Total Assets
$451M
Total Liabilities
$399M
Stockholders' Equity
$52M
Cash & Equivalents
$230M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$745M
-$885M
+15.8%
Net Income
-$739M
-$846M
+12.7%
← Q4 2024
All Quarters
Q1 2025 →